Anna Perols

459 total citations
15 papers, 381 citations indexed

About

Anna Perols is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Anna Perols has authored 15 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Anna Perols's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Click Chemistry and Applications (3 papers). Anna Perols is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Radiopharmaceutical Chemistry and Applications (11 papers) and Click Chemistry and Applications (3 papers). Anna Perols collaborates with scholars based in Sweden, Finland and Netherlands. Anna Perols's co-authors include Amelie Eriksson Karlström, Vladimir Tolmachev, Anna Orlova, Hadis Honarvar, Joanna Strand, Mohamed Altai, Ram Kumar Selvaraju, Mattias Sandström, Johan Rajander and Fréderic Boschetti and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Anna Perols

15 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Perols Sweden 12 273 139 133 57 46 15 381
Anne-Line Anderson United States 9 416 1.5× 174 1.3× 168 1.3× 29 0.5× 39 0.8× 11 521
Blesida Punzalan United States 11 202 0.7× 116 0.8× 142 1.1× 22 0.4× 67 1.5× 19 419
Jesse J. Parry United States 13 263 1.0× 174 1.3× 133 1.0× 28 0.5× 58 1.3× 21 489
Florian Kampmeier Germany 11 239 0.9× 145 1.0× 174 1.3× 39 0.7× 52 1.1× 14 421
Wen Ping Li United States 6 181 0.7× 108 0.8× 78 0.6× 31 0.5× 42 0.9× 8 345
Louis Allott United Kingdom 11 306 1.1× 145 1.0× 89 0.7× 57 1.0× 46 1.0× 28 420
Thomas R. Dilling United States 10 189 0.7× 96 0.7× 119 0.9× 78 1.4× 81 1.8× 15 357
Amanda J. Boyle Canada 11 249 0.9× 107 0.8× 81 0.6× 32 0.6× 66 1.4× 23 428
Elisabeth Miot‐Noirault France 14 194 0.7× 120 0.9× 191 1.4× 31 0.5× 46 1.0× 31 469
Brandon Carney United States 11 112 0.4× 325 2.3× 227 1.7× 37 0.6× 54 1.2× 19 502

Countries citing papers authored by Anna Perols

Since Specialization
Citations

This map shows the geographic impact of Anna Perols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Perols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Perols more than expected).

Fields of papers citing papers by Anna Perols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Perols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Perols. The network helps show where Anna Perols may publish in the future.

Co-authorship network of co-authors of Anna Perols

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Perols. A scholar is included among the top collaborators of Anna Perols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Perols. Anna Perols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tolmachev, Vladimir, Tove J. Grönroos, Cheng‐Bin Yim, et al.. (2018). Molecular design of radiocopper-labelled Affibody molecules. Scientific Reports. 8(1). 6542–6542. 12 indexed citations
2.
Tolmachev, Vladimir, Cheng‐Bin Yim, Johan Rajander, et al.. (2017). Comparative Evaluation of Anti-HER2 Affibody Molecules Labeled with 64Cu Using NOTA and NODAGA. Contrast Media & Molecular Imaging. 2017. 1–12. 49 indexed citations
3.
Dev, Apurba, Andreas Kaiser, Anna Perols, et al.. (2016). Electrokinetic effect for molecular recognition: A label-free approach for real-time biosensing. Biosensors and Bioelectronics. 82. 55–63. 11 indexed citations
4.
5.
Altai, Mohamed, Anna Perols, Bogdan Mitran, et al.. (2015). Feasibility of Affibody-Based Bioorthogonal Chemistry–Mediated Radionuclide Pretargeting. Journal of Nuclear Medicine. 57(3). 431–436. 50 indexed citations
6.
Perols, Anna & Amelie Eriksson Karlström. (2014). Site-Specific Photoconjugation of Antibodies Using Chemically Synthesized IgG-Binding Domains. Bioconjugate Chemistry. 25(3). 481–488. 39 indexed citations
7.
Rönnlund, Daniel, Lei Xu, Anna Perols, et al.. (2014). Multicolor Fluorescence Nanoscopy by Photobleaching: Concept, Verification, and Its Application To Resolve Selective Storage of Proteins in Platelets. ACS Nano. 8(5). 4358–4365. 27 indexed citations
9.
Strand, Joanna, Hadis Honarvar, Anna Perols, et al.. (2013). Influence of Macrocyclic Chelators on the Targeting Properties of 68Ga-Labeled Synthetic Affibody Molecules: Comparison with 111In-Labeled Counterparts. PLoS ONE. 8(8). e70028–e70028. 50 indexed citations
10.
Honarvar, Hadis, Anna Perols, Joanna Strand, et al.. (2012). Influence of DOTA chelator position on biodistribution and targeting properties of 111 In-labelled anti-HER2 affibody molecules. European Journal of Nuclear Medicine and Molecular Imaging. 39. 1 indexed citations
11.
Perols, Anna, Hadis Honarvar, Joanna Strand, et al.. (2012). Influence of DOTA Chelator Position on Biodistribution and Targeting Properties of 111In-Labeled Synthetic Anti-HER2 Affibody Molecules. Bioconjugate Chemistry. 23(8). 1661–1670. 38 indexed citations
12.
Altai, Mohamed, Anna Perols, Amelie Eriksson Karlström, et al.. (2011). Preclinical evaluation of anti-HER2 Affibody molecules site-specifically labeled with 111In using a maleimido derivative of NODAGA. Nuclear Medicine and Biology. 39(4). 518–529. 15 indexed citations
13.
Altai, Mohamed, Anna Perols, Amelie Eriksson Karlström, et al.. (2011). Evaluation of a maleimido derivative of NODAGA for site-specific In-111-labeling of Affibody molecules. European Journal of Nuclear Medicine and Molecular Imaging. 38. 2 indexed citations
14.
Malmberg, Jennie, Anna Perols, Zohreh Varasteh, et al.. (2011). Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts. European Journal of Nuclear Medicine and Molecular Imaging. 39(3). 481–492. 38 indexed citations
15.
Tolmachev, Vladimir, Mohamed Altai, Mattias Sandström, et al.. (2011). Evaluation of a Maleimido Derivative of NOTA for Site-Specific Labeling of Affibody Molecules. Bioconjugate Chemistry. 22(5). 894–902. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026